CHECKMATE PHARMACEUTICALS IN - COM (CMPI)

CUSIP: 162818108

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COM
Total 13F shares
16,249,035
Share change
-59,590
Total reported value
$64,507,000
Price per share
$3.97
Number of holders
27
Value change
-$649,689
Number of buys
8
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 162818108?
CUSIP 162818108 identifies CMPI - CHECKMATE PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHECKMATE PHARMACEUTICALS IN - COM (CMPI) as of Q3 2021

As of 30 Sep 2021, CHECKMATE PHARMACEUTICALS IN - COM (CMPI) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,249,035 shares. The largest 10 holders included venBio Partners LLC, Sofinnova Investments, Inc., Novo Holdings A/S, Clough Capital Partners L P, Medicxi Ventures Management (Jersey) Ltd, Omega Fund Management, LLC, FMR LLC, Sectoral Asset Management Inc, VANGUARD GROUP INC, and Ensign Peak Advisors, Inc. This page lists 27 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.